Johnson & Johnson's Levaquin risks were known, jury decides
|Our cover story, Achilles Heel, documented Johnson & Johnson's efforts to prove its drug was safe|
Calvin Christensen, 84, claimed that taking the drug Levaquin caused his Achilles tendon to rupture. But the drug maker successfully argued that Christensen's doctor knew the risks and prescribed it anyway. Score: Johnson & Johnson, 1; the People, 1.
Next up: a tiebreaker trial in November.
The latest verdict is just a small battle in the ongoing war over whether Johnson & Johnson deliberately hid dangerous side effects of its antibiotic, Levaquin, in order to maximize profits.
|Sales revenue from Levaquin|
Schedin, now 83, was the first plaintiff in a series of lawsuits over Levaquin that now includes nearly 1,000 plaintiffs in Minnesota.
Christensen was the second case in the series, but it was tougher for the plaintiffs to win. Christensen had a number of health problems, and his doctor said that even knowing the risks of tendon rupture, Levaquin was the best option to combat his patient's severe case of pneumonia.
A third case in the series is now scheduled for federal court in Minneapolis this November, and the outcome of that trial may help the parties determine if it's time to settle. Separately, another multi-plaintiff Levaquin case begins in New Jersey in September.